SOPHiA GENETICS S.A.
NASDAQ:SOPH · NASDAQ Global Select
+$0.02 today
Vol 0.44M · Avg 0.10M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+79.02%
Period High
$5.52
Period Low
$2.99
Latest
$5.46
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Agilon Health, Inc.
NYSE:AGL
$1.80B
Alto Neuroscience, Inc.
NYSE:ANRO
$778.73M
National Research Corporation
NASDAQ:NRC
$401.27M
Simulations Plus, Inc.
NASDAQ:SLP
$369.15M
Cellectis S.A.
NASDAQ:CLLS
$311.28M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$300.45M
AC Immune S.A.
NASDAQ:ACIU
$240.69M
OptimizeRx Corporation
NASDAQ:OPRX
$94.01M
Definitive Healthcare Corp.
NASDAQ:DH
$85.40M
Nakamoto Inc.
NASDAQ:NAKA
$72.13M
What is the latest SOPH filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does SOPH have?
Intrinsic Alpha currently shows 20 recent filings for SOPH.
Explore More
Continue the stock analysis
Jump to another research area for this company.